1: Kountouras J, Kazakos E, Kyrailidi F, Polyzos SA, Zavos C, Arapoglou S,
Boziki M, Mouratidou MC, Tzitiridou-Chatzopoulou M, Chatzopoulos D, Doulberis M,
Papaefthymiou A, Vardaka E. Innate immunity and nonalcoholic fatty liver
disease. Ann Gastroenterol. 2023 May-Jun;36(3):244-256. doi:
10.20524/aog.2023.0793. Epub 2023 Apr 8. PMID: 37144011; PMCID: PMC10152810.
2: Ntona S, Papaefthymiou A, Kountouras J, Gialamprinou D, Kotronis G, Boziki M,
Polyzos SA, Tzitiridou M, Chatzopoulos D, Thavayogarajah T, Gkolia I, Ntonas G,
Vardaka E, Doulberis M. Impact of nonalcoholic fatty liver disease-related
metabolic state on depression. Neurochem Int. 2023 Feb;163:105484. doi:
10.1016/j.neuint.2023.105484. Epub 2023 Jan 10. PMID: 36634820.
3: Doulberis M, Papaefthymiou A, Polyzos SA, Vardaka E, Tzitiridou-Chatzopoulou
M, Chatzopoulos D, Koffas A, Papadopoulos V, Kyrailidi F, Kountouras J. Local
and systemic autoimmune manifestations linked to hepatitis A infection. Acta
Gastroenterol Belg. 2023 Jul-Sep;86(3):429-436. doi: 10.51821/86.3.11299. PMID:
37814559.
4: Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatitis C. J Viral
Hepat. 2003 Sep;10(5):335-42. doi: 10.1046/j.1365-2893.2003.00452.x. PMID:
12969183.
5: Kountouras J, Kazakos E, Polyzos SA, Papaefthymiou A, Zavos C, Tzitiridou-
Chatzopoulou M, Chatzopoulos D, Vardaka E, Gatopoulou A, Kyrailidi F, Mouratidou
MC, Doulberis M. Potential impact of trained innate immunity on the
pathophysiology of metabolic dysfunction-associated fatty liver disease. Clin
Immunol. 2023 Nov;256:109776. doi: 10.1016/j.clim.2023.109776. Epub 2023 Sep 22.
PMID: 37742792.
6: Kountouras J, Zavos C, Chatzopoulos D. Immunomodulatory benefits of
cyclosporine A in inflammatory bowel disease. J Cell Mol Med. 2004 Jul-
Sep;8(3):317-28. doi: 10.1111/j.1582-4934.2004.tb00321.x. PMID: 15491507; PMCID:
PMC6740145.
7: Kountouras J, Zavos C, Chatzopoulos D. Helicobacter pylori and glaucoma.
Ophthalmology. 2003 Dec;110(12):2433-4; author reply 2434. doi:
10.1016/j.ophtha.2003.09.014. PMID: 14644740.
8: Kountouras J, Tzitiridou-Chatzopoulou M, Papaefthymiou A, Chatzopoulos D,
Doulberis M. COVID-19 mRNA Vaccine Effectiveness against Elderly Frail People.
Medicina (Kaunas). 2023 Jan 19;59(2):202. doi: 10.3390/medicina59020202. PMID:
36837403; PMCID: PMC9962607.
9: Kountouras J, Papaefthymiou A, Polyzos SA, Liatsos C, Tzitiridou-Chatzopoulou
M, Chatzopoulos D, Vardaka E, Gialamprinou D, Kotronis G, Thavayogarajah T,
Doulberis M. Adverse Outcomes of E-cigarette in Inflammatory Bowel Disease. Dig
Dis Sci. 2023 Feb;68(2):701-702. doi: 10.1007/s10620-022-07642-1. Epub 2022 Aug
5. PMID: 35930122.
10: Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper
gastrointestinal diseases. Hepatogastroenterology. 2001 May-Jun;48(39):743-51.
PMID: 11462918.
11: Kountouras J, Polyzos SA, Kazakos E, Zavos C, Grigoriadis N, Papanikolaou
IS, Vardaka E, Tzilves D, Chatzopoulos D, Tzitiridou-Chatzopoulou M, Touloumtzi
M, Doulberis M, Papaefthymiou A. Letter: Role of Helicobacter pylori and
metabolic syndrome-related insulin resistance and lipotoxicity in the
pathogenesis of MAFLD and MASH. Aliment Pharmacol Ther. 2024 Sep;60(5):660-661.
doi: 10.1111/apt.18124. Epub 2024 Jul 30. PMID: 39076103.
12: Kountouras J, Zavos C, Chatzopoulos D, Zavos N, Boura P, Safioleas M.
Locoregional immunochemotherapy in primary and metastatic liver disease: meta-
analysis and review of literature. Hepatogastroenterology. 2003 Sep-
Oct;50(53):1506-10. PMID: 14571774.
13: Kyrgidis A, Kountouras J, Zavos C, Chatzopoulos D. New molecular concepts of
Barrett's esophagus: clinical implications and biomarkers. J Surg Res. 2005 May
15;125(2):189-212. doi: 10.1016/j.jss.2004.12.022. PMID: 15854673.
14: Kountouras J, Zavos C, Chatzopoulos D. Apoptosis in hepatocellular
carcinoma. Hepatogastroenterology. 2003 Jan-Feb;50(49):242-9. PMID: 12630032.
15: Kountouras J, Papaefthymiou A, Polyzos SA, Vardaka E, Kyrailidi F,
Mouratidou MC, Zavos C, Kazakos E, Chatzopoulos D, Tzitiridou-Chatzopoulou M,
Tzilves D, Liatsos C, Touloumtzi M, Doulberis M. Autonomic Dysfunction and
Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve
Prolapse Syndrome. J Neurogastroenterol Motil. 2023 Jul 30;29(3):403-404. doi:
10.5056/jnm23061. PMID: 37417268; PMCID: PMC10334193.
16: Kountouras J, Gialamprinou D, Kotronis G, Papaefthymiou A, Economidou E,
Soteriades ES, Vardaka E, Chatzopoulos D, Tzitiridou-Chatzopoulou M, Papazoglou
DD, Doulberis M. <i>Ofeleein i mi Vlaptin</i>-Volume II: Immunity Following
Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management
at Post-Two Years SARS-CoV-2 Pandemic. Medicina (Kaunas). 2022 Feb 17;58(2):309.
doi: 10.3390/medicina58020309. PMID: 35208631; PMCID: PMC8874934.
17: Kountouras J, Mylopoulos N, Boura P, Bessas C, Chatzopoulos D, Venizelos J,
Zavos C. Relationship between Helicobacter pylori infection and glaucoma.
Ophthalmology. 2001 Mar;108(3):599-604. doi: 10.1016/s0161-6420(00)00598-4.
PMID: 11237916.
18: Kountouras J, Zavos C, Chatzopoulos D. Primary open-angle glaucoma:
pathophysiology and treatment. Lancet. 2004 Oct 9-15;364(9442):1311-2. doi:
10.1016/S0140-6736(04)17179-1. PMID: 15474127.
19: Kountouras J, Zavos C, Chatzopoulos D. H pylori infection and reflux
oesophagitis. Gut. 2004 Jun;53(6):912. PMID: 15138222; PMCID: PMC1774071.
20: Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. Helicobacter pylori and
gastro-oesophageal reflux disease. Lancet. 2006 Sep 16;368(9540):986; author
reply 986-7. doi: 10.1016/S0140-6736(06)69405-1. PMID: 16980103.
21: Kountouras J, Vardaka E, Zavos C, Chatzopoulos D, Tzitiridou-Chatzopoulou M,
Tzilves D, Zournatzidou G, Kyrailidou F, Mouratidou MC. Letter: Potential impact
of Helicobacter pylori infection on oesophageal disorders in chronic liver
disease. Aliment Pharmacol Ther. 2024 Oct;60(8):1139-1140. doi:
10.1111/apt.18220. Epub 2024 Sep 2. PMID: 39223754.
22: Kountouras J, Zavos C, Deretzi G, Gavalas E, Chatzopoulos D, Katsinelos P,
Tsiaousi E, Gagalis S, Polyzos SA, Venizelos I. Potential implications of
Helicobacter pylori-related neutrophil-activating protein. World J
Gastroenterol. 2012 Feb 7;18(5):489-90. doi: 10.3748/wjg.v18.i5.489. PMID:
22346256; PMCID: PMC3270508.
23: Kountouras J, Papaefthymiou A, Polyzos SA, Liatsos C, Tzitiridou-
Chatzopoulou M, Chatzopoulos D, Vardaka E, Gialambrinou D, Kotronis G, Doulberis
M. Potential impact of Helicobacter pylori and metabolic syndrome-related non-
alcoholic fatty liver disease on cardio-cerebrovascular disease. Metabolism.
2022 Oct;135:155276. doi: 10.1016/j.metabol.2022.155276. Epub 2022 Aug 6. PMID:
35940250.
24: Kountouras J, Zavos C, Chatzopoulos D. Apoptotic and anti-angiogenic
strategies in liver and gastrointestinal malignancies. J Surg Oncol. 2005 Jun
15;90(4):249-59. doi: 10.1002/jso.20254. PMID: 15906369.
25: Kountouras J, Papaefthymiou A, Liatsos C, Tzitiridou-Chatzopoulou M,
Chatzopoulos D, Gialamprinou D, Kotronis G, Vardaka E, Kazakos E, Doulberis M.
Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation
on major adverse cardiovascular events". Clin Nutr. 2022 Aug;41(8):1855-1856.
doi: 10.1016/j.clnu.2022.06.015. Epub 2022 Jun 24. PMID: 35780067.
26: Kountouras J, Polyzos SA, Zavos C, Kazakos E, Tzitiridou-Chatzopoulou M,
Chatzopoulos D, Stogianni A, Touloumtzi M, Arapoglou S, Vardaka E. Relationship
Mitral valve prolapse syndrome and duodenal ulcer disease with concomitant
autonomic dysfunction. Caspian J Intern Med. 2025 Mar 21;16(2):328-335. doi:
10.22088/cjim.16.2.328. PMID: 40575754; PMCID: PMC12189005.
27: Kountouras J, Boziki M, Gavalas E, Zavos C, Grigoriadis N, Deretzi G,
Tzilves D, Katsinelos P, Tsolaki M, Chatzopoulos D, Venizelos I. Eradication of
Helicobacter pylori may be beneficial in the management of Alzheimer's disease.
J Neurol. 2009 May;256(5):758-67. doi: 10.1007/s00415-009-5011-z. Epub 2009 Feb
25. PMID: 19240960.
28: Kountouras J, Tsolaki M, Boziki M, Gavalas E, Zavos C, Stergiopoulos C,
Kapetanakis N, Chatzopoulos D, Venizelos I. Association between Helicobacter
pylori infection and mild cognitive impairment. Eur J Neurol. 2007
Sep;14(9):976-82. doi: 10.1111/j.1468-1331.2007.01827.x. PMID: 17718688.
29: Kountouras J, Papaefthymiou A, Polyzos SA, Kazakos E, Tzilves D, Touloumtzi
M, Chatzopoulos D, Tzitiridou-Chatzopoulou M, Liatsos C, Zavos C, Kavaliotis J,
Kulaksiz H, Doulberis M. Letter: higher severe outcomes among Helicobacter
pylori-related lean patients with non-alcoholic fatty liver disease and
metabolic comorbidities. Aliment Pharmacol Ther. 2023 May;57(10):1186-1187. doi:
10.1111/apt.17484. PMID: 37094305.
30: Kountouras J, Zavos C, Chatzopoulos D. Apoptosis and autoimmunity as
proposed pathogenetic links between Helicobacter pylori infection and idiopathic
achalasia. Med Hypotheses. 2004;63(4):624-9. doi: 10.1016/j.mehy.2004.04.003.
PMID: 15325006.
31: Gavalas E, Kountouras J, Stergiopoulos C, Zavos C, Gisakis D, Nikolaidis N,
Giouleme O, Chatzopoulos D, Kapetanakis N. Efficacy and safety of infliximab in
steroid-dependent ulcerative colitis patients. Hepatogastroenterology. 2007
Jun;54(76):1074-9. PMID: 17629042.
32: Kountouras J, Doulberis M, Polyzos SA, Tzitiridou M, Chatzopoulos D,
Gialamprinou D, Kotronis G, Vardaka E, Liatsos C, Papaefthymiou A. A potential
impact of Helicobacter pylori-related metabolic syndrome on early and long-term
outcomes of bariatric surgery. Gastrointest Endosc. 2022 Dec;96(6):1088-1089.
doi: 10.1016/j.gie.2022.07.003. PMID: 36404088.
33: Kountouras J, Mylopoulos N, Chatzopoulos D, Zavos C, Boura P, Konstas AG,
Venizelos J. Eradication of Helicobacter pylori may be beneficial in the
management of chronic open-angle glaucoma. Arch Intern Med. 2002 Jun
10;162(11):1237-44. doi: 10.1001/archinte.162.11.1237. PMID: 12038941.
34: Kountouras J, Papaefthymiou A, Zavos C, Chatzopoulos D, Tzitiridou-
Chatzopoulou M, Kavaliotis J, Tzilves D, Lazaraki G, Vardaka E, Doulberis M.
Viewing the Current Puzzling Issue of COVID-19 Vaccination Safety in Older
Adults. J Am Med Dir Assoc. 2023 Oct;24(10):1612-1613. doi:
10.1016/j.jamda.2023.07.010. Epub 2023 Aug 12. PMID: 37582481.
35: Moschos JM, Kouklakis G, Vradelis S, Zezos P, Pitiakoudis M, Chatzopoulos D,
Zavos C, Kountouras J. Patients with established gastro-esophageal reflux
disease might benefit from <i>Helicobacter pylori</i> eradication. Ann
Gastroenterol. 2014;27(4):352-356. PMID: 25330805; PMCID: PMC4188932.
36: Kountouras J, Zavos C, Polyzos SA, Tzitiridou-Chatzopoulou M, Polyzou-Laspia
P, Chatzopoulos D, Doulberis M, Vardaka E, Papanikolaou IS. Helicobacter pylori
and Porphyromonas gingivalis as risk factors in the enteric metaplasia-
dysplasia-oncogenesis sequence. Arab J Gastroenterol. 2025 Nov;26(4):318-319.
doi: 10.1016/j.ajg.2025.07.001. Epub 2025 Sep 24. PMID: 40998663.
37: Kountouras J, Kouklakis G, Zavos C, Chatzopoulos D, Moschos J, Molyvas E,
Zavos N. Apoptosis, inflammatory bowel disease and carcinogenesis: overview of
international and Greek experiences. Can J Gastroenterol. 2003 Apr;17(4):249-58.
doi: 10.1155/2003/527060. PMID: 12704469.
38: Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. New aspects of
Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res.
2008 May 1;146(1):149-58. doi: 10.1016/j.jss.2007.06.011. Epub 2007 Jul 27.
PMID: 17720195.
39: Kountouras J, Zavos C, Chatzopoulos D. Induction of apoptosis as a proposed
pathophysiological link between glaucoma and Helicobacter pylori infection. Med
Hypotheses. 2004;62(3):378-81. doi: 10.1016/j.mehy.2003.11.013. PMID: 14975507.
40: Kountouras J, Zavos C, Chatzopoulos D. Therapy for colorectal cancer. N Engl
J Med. 2005 Apr 28;352(17):1820-1; author reply 1822. doi:
10.1056/NEJM200504283521720. Erratum in: N Engl J Med. 2005 Jun 16:352(24):2563.
PMID: 15858197.
41: Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P,
Chatzopoulos D, Venizelos I. Relationship between Helicobacter pylori infection
and Alzheimer disease. Neurology. 2006 Mar 28;66(6):938-40. doi:
10.1212/01.wnl.0000203644.68059.5f. PMID: 16567719.
42: Lazaraki G, Kountouras J, Metallidis S, Vrettou E, Tzioufa V, Germanidis G,
Chatzopoulos D, Zavos C, Giannoulis K, Nikolaidis P. Helicobacter pylori
infection upregulates endothelial nitric oxide synthase expression and induces
angiogenesis in gastric mucosa of dyspeptic patients. Eur J Gastroenterol
Hepatol. 2008 May;20(5):441-9. doi: 10.1097/MEG.0b013e3282f4c35a. PMID:
18403947.
43: Kountouras J, Zavos C, Chatzopoulos D. New concepts of molecular biology on
gastric carcinogenesis. Hepatogastroenterology. 2005 Jul-Aug;52(64):1305-12.
PMID: 16001683.
44: Kountouras J, Doulberis M, Polyzos SA, Kazakos E, Vardaka E, Tzitiridou-
Chatzopoulou M, Chatzopoulos D, Liatsos C, Kyriakopoulos A, Papaefthymiou A.
Emerging parameters relevant to the management of antimicrobial-resistant
Helicobacter pylori infection. Intern Med J. 2022 Sep;52(9):1654-1655. doi:
10.1111/imj.15872. PMID: 36100561.
45: Kountouras J, Kazakos E, Chatzopoulos D, Doulberis M. Helicobacter pylori
Eradication Regimens With Adjuvant Probiotics Efficacy in the Treatment of
Hepatic Encephalopathy. Liver Int. 2025 Apr;45(4):e16215. doi:
10.1111/liv.16215. PMID: 40083248.
46: Kountouras J, Boziki M, Gavalas E, Zavos C, Deretzi G, Grigoriadis N,
Tsolaki M, Chatzopoulos D, Katsinelos P, Tzilves D, Zabouri A, Michailidou I.
Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's
disease. Int J Neurosci. 2009;119(6):765-77. doi: 10.1080/00207450902782083.
PMID: 19326283.
47: Kountouras J, Kazakos E, Polyzos SA, Chatzopoulos D, Tzitiridou-Chatzopoulou
M, Doulberis M, Papaefthymiou A, Vardaka E. GM-CSF as a potential candidate of a
vaccine-induced reduction of Helicobacter pylori infection. Helicobacter. 2022
Jun;27(3):e12884. doi: 10.1111/hel.12884. Epub 2022 Mar 7. PMID: 35257445.
48: Kountouras J, Chatzopoulos D, Zavos C, Boura P, Venizelos J, Kalis A.
Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease
and irritable bowel syndrome. Hepatogastroenterology. 2002 Jan-Feb;49(43):193-7.
PMID: 11941952.
49: Kountouras J, Gavalas E, Zavos C, Stergiopoulos C, Chatzopoulos D,
Kapetanakis N, Gisakis D. Alzheimer's disease and Helicobacter pylori infection:
Defective immune regulation and apoptosis as proposed common links. Med
Hypotheses. 2007;68(2):378-88. doi: 10.1016/j.mehy.2006.06.052. Epub 2006 Sep
18. PMID: 16979298.
50: Kountouras J, Zavos C, Chatzopoulos D. Salt intake and Helicobacter pylori
infection. J Hypertens. 2004 Dec;22(12):2397. doi:
10.1097/00004872-200412000-00023. PMID: 15614036.
51: Kountouras J, Zavos C, Polyzos SA, Deretzi G, Vardaka E, Giartza-Taxidou E,
Katsinelos P, Rapti E, Chatzopoulos D, Tzilves D, Stergiopoulos C, Christodoulou
K. Helicobacter pylori infection and Parkinson's disease: apoptosis as an
underlying common contributor. Eur J Neurol. 2012 Jun;19(6):e56. doi:
10.1111/j.1468-1331.2012.03695.x. PMID: 22577753.
52: Kountouras J, Zavos C, Polyzos SA, Vardaka E, Kazakos E, Chatzopoulou-
Tzitiridou M, Chatzopoulos D, Tzivras D, Papanikolaou IS, Liatsos C, Gavalas E.
Potential Influence of Helicobacter Pylori on Glaucoma-Related Alterations of
Ocular Surface Microbiota and Dry Eye Disease Pathophysiology. Invest Ophthalmol
Vis Sci. 2025 Dec 1;66(15):72. doi: 10.1167/iovs.66.15.72. PMID: 41533944;
PMCID: PMC12758431.
53: Kountouras J, Zavos C, Chatzopoulos D. A concept on the role of Helicobacter
pylori infection in autoimmune pancreatitis. J Cell Mol Med. 2005 Jan-
Mar;9(1):196-207. doi: 10.1111/j.1582-4934.2005.tb00349.x. PMID: 15784177;
PMCID: PMC6741421.
54: Lazaraki G, Kountouras J, Metallidis S, Dokas S, Bakaloudis T, Chatzopoulos
D, Gavalas E, Zavos C. Single use of fentanyl in colonoscopy is safe and
effective and significantly shortens recovery time. Surg Endosc. 2007
Sep;21(9):1631-6. doi: 10.1007/s00464-007-9215-y. Epub 2007 Feb 16. PMID:
17762959.
55: Kountouras J, Papaefthymiou A, Polyzos SA, Liatsos C, Vardaka E, Touloumtzi
M, Tzitiridou-Chatzopoulou M, Chatzopoulos D, Doulberis M. Letter to the Editor
Regarding "The Association of Helicobacter pylori, Eradication, and Early
Complications of Laparoscopic Sleeve Gastrectomy" by Abeid et al. Obes Surg.
2022 Jun;32(6):2079-2080. doi: 10.1007/s11695-022-06045-5. Epub 2022 Apr 12.
PMID: 35412262.
56: Kountouras J, Mylopoulos N, Konstas AG, Zavos C, Chatzopoulos D, Boukla A.
Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of
patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp
Ophthalmol. 2003 Nov;241(11):884-90. doi: 10.1007/s00417-003-0779-5. Epub 2003
Oct 24. PMID: 14576945.
57: Kountouras J, Zavos C, Touloumis L, Chatzopoulos D. Oral furosemide-induced
natriuresis: a potential method for identifying cirrhotic patients with
refractory ascites. Liver Int. 2010 Oct;30(9):1395; author reply 1395-6. doi:
10.1111/j.1478-3231.2010.02329.x. PMID: 20731771.
58: Kountouras J, Zavos C, Chatzopoulos D. Ocular and systemic side effects of
latanoprost. Eye (Lond). 2005 Jul;19(7):804-5; author reply 805-6. doi:
10.1038/sj.eye.6701634. PMID: 15359267.
59: Chatzopoulos D, Kyrgidis A, Kountouras J, Zavos C, Molyvas E, Venizelos I.
Bax upregulation may provide a rationale for the low incidence of esophageal
adenocarcinoma in a Greek cohort of patients with Barrett's esophagus.
Hepatogastroenterology. 2007 Apr-May;54(75):705-9. PMID: 17591046.
60: Kountouras J, Zavos C, Chatzopoulos D. Less H. pylori not necessarily more
GERD. Am J Gastroenterol. 2005 Jan;100(1):249-50. doi:
10.1111/j.1572-0241.2005.41277_4.x. PMID: 15654809.
61: Kountouras J, Zavos C, Chatzopoulos D. Pathogenetic links between colorectal
neoplasia and Barrett's esophagus. Gastrointest Endosc. 2006 Aug;64(2):298. doi:
10.1016/j.gie.2006.04.002. PMID: 16860098.
62: Papagoras C, Kountouras J, Brilakis S, Chatzopoulos D, Zavos C, Topalidis A.
Rheumatic-like syndrome as a symptom of underlying gastric cancer. Clin
Rheumatol. 2007 Jun;26(6):1029-31. doi: 10.1007/s10067-006-0268-4. Epub 2006 Mar
30. PMID: 16572285.
63: Kountouras J, Deretzi G, Zavos C, Karatzoglou P, Touloumis L, Nicolaides T,
Chatzopoulos D, Venizelos I. Association between Helicobacter pylori infection
and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2005
Feb;12(2):139-43. doi: 10.1111/j.1468-1331.2004.00977.x. PMID: 15679702.
64: Kountouras J, Gavalas E, Deretzi G, Boziki M, Zavos C, Chatzopoulos D,
Katsinelos P, Giartza-Taxidou E, Grigoriadis N, Venizelos I. Helicobacter pylori
with or without its neutrophil-activating protein may be the common denominator
associated with multiple sclerosis and neuromyelitis optica. Mult Scler. 2010
Mar;16(3):376-7; author reply 378-9. doi: 10.1177/1352458509360550. PMID:
20203152.
65: Kountouras J, Chatzopoulos D, Zavos C, Polyzos SA, Giartza-Taxidou E,
Vardaka E, Molyvas E, Kouklakis G, Tsiaousi E, Klonizakis P. Helicobacter pylori
infection might contribute to esophageal adenocarcinoma progress in
subpopulations with gastroesophageal reflux disease and Barrett's esophagus.
Helicobacter. 2012 Oct;17(5):402-3. doi: 10.1111/j.1523-5378.2012.00963.x. Epub
2012 May 27. PMID: 22967125.
66: Kountouras J, Zavos C, Chatzopoulos D. Autoimmune pancreatitis, Helicobacter
pylori infection, and apoptosis: a proposed relationship. Pancreas. 2005
Mar;30(2):192-3. doi: 10.1097/01.mpa.0000151576.91790.f8. PMID: 15714146.
67: Kountouras J, Gavalas E, Boziki M, Zavos C, Deretzi G, Grigoriadis N,
Tsiaousi E, Katsinelos P, Chatzopoulos D, Tzilves D, Kouklakis G. High
prevalence of dementia and cognitive impairment in indigenous Australians.
Neurology. 2009 Aug 11;73(6):487; author reply 487-8. doi:
10.1212/WNL.0b013e3181ab9a93. PMID: 19667328.
68: Kountouras J, Zavos C, Chatzopoulos D, Romiopoulos I, Polyzos SA,
Kapetanakis N, Tsiaousi E, Vardaka E, Deretzi G, Tsarouchas G, Katsinelos P.
Letter: is Helicobacter pylori behind Barrett's oesophagus and colorectal
neoplasms? Aliment Pharmacol Ther. 2013 Apr;37(8):837. doi: 10.1111/apt.12247.
PMID: 23496313.
69: Kountouras J, Zavos C, Chatzopoulos D, Polyzos SA, Deretzi G, Simeonidou C,
Grigoriadis N, Vardaka E, Kountouras C, Loli E, Moschos J, Kouklakis G,
Katsinelos P. Letter: low risk of colorectal cancer in a Greek cohort of
inflammatory bowel disease patients. Aliment Pharmacol Ther. 2014
May;39(9):1001-2. doi: 10.1111/apt.12689. PMID: 24689353.
70: Kountouras J, Zavos C, Chatzopoulos D. Re: "Prognostic significance of Bcl-
xL in human hepatocellular carcinoma". Surgery. 2005 Feb;137(2):265-6. doi:
10.1016/j.surg.2004.06.038. PMID: 15674216.
71: Zavos C, Kountouras J, Chatzopoulos D. Helicobacter pylori infection in
dialysis patients undergoing kidney transplantation. Saudi J Kidney Dis Transpl.
2006 Dec;17(4):579-80. PMID: 17186698.
72: Kountouras J, Zavos C, Deretzi G, Polyzos SA, Gavalas E, Tsiaousi E,
Giartza-Taxidou E, Chatzopoulos D, Michael S, Tsarouchas G. Neuroprotection in
glaucoma: is there a future role of Helicobacter pylori eradication? Exp Eye
Res. 2011 May;92(5):436-8. doi: 10.1016/j.exer.2011.02.017. Epub 2011 Mar 4.
PMID: 21377461.
73: Kountouras J, Zavos C, Chatzopoulos D. Induction of interleukin-8 expression
by Helicobacter pylori infection in patients with endoscopy-negative
gastroesophageal reflux disease. Am J Gastroenterol. 2004 Dec;99(12):2500-1;
author reply 2501-2. doi: 10.1111/j.1572-0241.2004.41389_3.x. PMID: 15571602.
74: Kountouras J, Zavos C, Chatzopoulos D. Body mass index and socioeconomic
status measured in adolescence, country of origin, and the incidence of
gastroesophageal adenocarcinoma in a cohort of 1 million men. Cancer. 2014 Mar
1;120(5):768. doi: 10.1002/cncr.28489. Epub 2013 Nov 18. PMID: 24249523.
75: Kountouras J, Patsiaoura K, Zavos C, Chatzopoulos D, Katsinelos P, Tantsi N,
Polyzos SA, Giouleme O, Gigi E, Deretzi G, Simeonidou C, Grigoriadis N, Boura P.
Letter: apoptosis and hepatic fibrosis in chronic hepatitis B. Aliment Pharmacol
Ther. 2014 May;39(9):996. doi: 10.1111/apt.12643. PMID: 24689347.
76: Kountouras J, Chatzopoulos D, Zavos C. Eradication of Helicobacter pylori
might halt the progress to oesophageal adenocarcinoma in patients with gastro-
oesophageal reflux disease and Barrett's oesophagus. Med Hypotheses.
2007;68(5):1174-5. doi: 10.1016/j.mehy.2006.11.020. Epub 2006 Dec 29. PMID:
17196756.
77: Kountouras J, Zavos C, Gavalas E, Boziki M, Chatzopoulos D, Katsinelos P.
Normal-tension glaucoma and Alzheimer's disease: Helicobacter pylori as a
possible common underlying risk factor. Med Hypotheses. 2007;68(1):228-9. doi:
10.1016/j.mehy.2006.07.008. Epub 2006 Sep 15. PMID: 16978795.
78: Kountouras J, Zavos C, Chatzopoulos D. Helicobacter pylori infection and the
risk for coronary artery disease. Saudi Med J. 2004 May;25(5):679-80, author
reply 680-1. PMID: 15138546.
79: Kountouras J, Kazakos E, Polyzos SA, Vardaka E, Doulberis M, Papaefthymiou
A, Mouratidou MC, Tzitiridou-Chatzopoulou M, Chatzopoulos D. Helicobacter pylori
and Porphyromonas gingivalis as candidate microbial biomarkers linking
periodontal disease, MASLD, and cardiovascular risk. Infection. 2026 May 11.
doi: 10.1007/s15010-026-02816-9. Epub ahead of print. PMID: 42113460.
80: Kountouras J, Zavos C, Chatzopoulos D. Anti-tumor necrosis factor therapy
for ulcerative colitis. Gastroenterology. 2005 Sep;129(3):1138-9. doi:
10.1053/j.gastro.2005.07.047. PMID: 16143158.
81: Kountouras J, Zavos C, Chatzopoulos D. Risk of extra-oesophageal
malignancies in Barrett's oesophagus. Scand J Gastroenterol. 2004
Dec;39(12):1314. doi: 10.1080/00365520410011452. PMID: 15743014.
82: Kountouras J, Zavos C, Chatzopoulos D. Apoptosis and apoptosis-related
proteins in inflammatory bowel disease. Apoptosis. 2004 Sep;9(5):657-8; author
reply 659. doi: 10.1023/b:appt.0000038058.83946.40. PMID: 15337851.
83: Zavos C, Kountouras J, Chatzopoulos D, Katsinelos P. Losing weight by
defaecating at night theory: The gastroenterologists' perspective. Med
Hypotheses. 2007;68(2):467-8. doi: 10.1016/j.mehy.2006.08.006. Epub 2006 Sep 27.
PMID: 17008026.
84: Zavos C, Kountouras J, Zavos N, Chatzopoulos D. Inhibition of tumour
necrosis factor-alpha in patients with chronic hepatitis C infection. Clin
Rheumatol. 2007 Feb;26(2):283. doi: 10.1007/s10067-006-0437-5. Epub 2006 Sep 27.
PMID: 17003955.
85: Kountouras J, Zavos C, Chatzopoulos D. The role of gastric Helicobacter
pylori infection in laryngopharyngeal reflux disease. Otolaryngol Head Neck
Surg. 2007 Feb;136(2):334; author reply 334-5. doi:
10.1016/j.otohns.2006.10.026. PMID: 17275574.
86: Kountouras J, Zavos C, Chatzopoulos D. Apoptotic markers in assessing
patients with chronic hepatitis C. Gastroenterology. 2005 May;128(5):1531-2;
author reply 1532-3. doi: 10.1053/j.gastro.2005.03.058. PMID: 15887146.
87: Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P. Molecular mechanisms
associated with aggressiveness of alpha-fetoprotein-positive gastric cancer.
Hepatogastroenterology. 2007 Mar;54(74):329-30. PMID: 17523267.
88: Kountouras J, Chatzopoulos D, Zavos C, Deretzi G, Polyzos SA, Gavalas E,
Klonizakis P, Vardaka E, Katsinelos P, Stergiopoulos C, Moschos J, Giartza-
Taxidou E. Ki-67 and Bax expression in esophageal mucosa might have implications
in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma.
Surg Endosc. 2012 Jan;26(1):283-4. doi: 10.1007/s00464-011-1864-1. PMID:
21858571.
